Pharmexcil to organise International Pharma Business Meet (Focus Africa) in Ahmedabad
Over 150 Indian delegates are likely to participate
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
’Empowered Patients’: A changing dynamic
‘Empowered Patients’ are expected to play an important role in the healthcare decision making process, opines Tapan J Ray,…
Indian pharmaceutical industry growth intact amid current headwinds faced by industry
Pharma MNCs have adopted India-focused strategies to tap the growing potential of the country’s pharma market, says Hitesh Sharma,…
Adapting to the evolving consumer landscape
Ankit Suri, Vice President, Tecnova India, predicts that both MNCs and Indian pharma companies will adopt new tools and business…
Indian pharmaceuticals: A long-term story
Inspite of attracive long term growth prospects, Anjan Sen, Director, Deloitte Touche Tohmatsu India, opines that field force…
Improved awareness will lead to better business
Dr Kiran Marthak, Vice Chairman, Medical Sub Committee- IDMA and Head Global Clinical Development, Lambda Therapeutic Research,…
Indian clinical research: A call to self regulate
The Indian clinical research industry is at the crossroads. If 2012 was a year of regulatory discussion and debate, 2013 will see…
Indian pharma: Emerging as global power in R&D
D K Aggarwal, CMD, SMC Investments and Advisors, says that collaboration between the Government and industry holds the key to…
Tech solutions to improve management of drug development programmes
Ted Gastineau, President, ICON Clinical Research explains how the increased use of technology is likely to lead to changes within…
IPR trends in 2013: An alloy of problems and solutions
Milind Sathe, Deputy General Manager-Projects, Unichem Laboratories expresses his views